Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.
Salcedo M, Lendvai N, Mastey D, Schlossman J, Hultcrantz M, Korde N, Mailankody S, Lesokhin A, Hassoun H, Smith E, Shah U, Diab V, Werner K, Landau H, Lahoud O, Drullinsky P, Shah G, Chung D, Scordo M, Giralt S, Landgren O. Salcedo M, et al. Clin Lymphoma Myeloma Leuk. 2020 Mar;20(3):198-200. doi: 10.1016/j.clml.2019.12.013. Epub 2019 Dec 26. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32001193 Free PMC article. Clinical Trial. No abstract available.
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition.
Pianko MJ, Devlin SM, Littmann ER, Chansakul A, Mastey D, Salcedo M, Fontana E, Ling L, Tavitian E, Slingerland JB, Slingerland AE, Clurman A, Gomes ALC, Taur Y, Pamer EG, Peled JU, van den Brink MRM, Landgren O, Lesokhin AM. Pianko MJ, et al. Among authors: salcedo m. Blood Adv. 2019 Jul 9;3(13):2040-2044. doi: 10.1182/bloodadvances.2019032276. Blood Adv. 2019. PMID: 31289031 Free PMC article.
Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy.
Eveillard M, Korde N, Ciardiello A, Diamond B, Lesokhin A, Mailankody S, Smith E, Hassoun H, Hultcrantz M, Shah U, Lu S, Salcedo M, Werner K, Rispoli J, Mastey D, Landgren O, Thoren K. Eveillard M, et al. Among authors: salcedo m. Clin Chim Acta. 2021 May;516:136-141. doi: 10.1016/j.cca.2021.01.021. Epub 2021 Feb 2. Clin Chim Acta. 2021. PMID: 33545108 Free PMC article.
Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2 ) in combination with lenalidomide and dexamethasone.
Korde N, Mastey D, Tavitian E, Mailankody S, Lesokhin A, Hassoun H, Smith EL, Lendvai N, Hultcrantz M, Shah U, Tan C, Lu S, Diamond B, Salcedo M, Werner K, Chung DJ, Scordo M, Shah GL, Lahoud O, Landau H, Arcila M, Ho C, Roshal M, Dogan A, Derkach A, Devlin SM, Giralt SA, Landgren O. Korde N, et al. Among authors: salcedo m. Am J Hematol. 2021 Jun 1;96(6):E193-E196. doi: 10.1002/ajh.26150. Epub 2021 Mar 19. Am J Hematol. 2021. PMID: 33661527 Free PMC article. Clinical Trial. No abstract available.
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
Landgren O, Hultcrantz M, Diamond B, Lesokhin AM, Mailankody S, Hassoun H, Tan C, Shah UA, Lu SX, Salcedo M, Werner K, Rispoli J, Caple J, Sams A, Verducci D, Jones K, Concepcion I, Ciardello A, Chansakul A, Schlossman J, Tavitian E, Shekarkhand T, Harrison A, Piacentini C, Rustad EH, Yellapantula V, Maclaughlan K, Maura F, Landau HJ, Scordo M, Chung DJ, Shah G, Lahoud OB, Thoren K, Murata K, Ramanathan L, Arcila ME, Ho C, Roshal M, Dogan A, Derkach A, Giralt SA, Korde N. Landgren O, et al. Among authors: salcedo m. JAMA Oncol. 2021 Jun 1;7(6):862-868. doi: 10.1001/jamaoncol.2021.0611. JAMA Oncol. 2021. PMID: 33856405 Free PMC article. Clinical Trial.
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study.
Mailankody S, Salcedo M, Tavitian E, Burge M, Korde N, Hassoun H, Lesokhin A, Lahoud O, Smith E, Hultcrantz M, Tan C, Shah U, Devlin S, Landgren O. Mailankody S, et al. Among authors: salcedo m. Leuk Lymphoma. 2022 Nov;63(11):2760-2761. doi: 10.1080/10428194.2022.2095626. Epub 2022 Jul 15. Leuk Lymphoma. 2022. PMID: 35838493 No abstract available.
A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy.
Nath K, Shekarkhand T, Salcedo M, Derkach A, Rueda S, Chansakul A, Hulcrantz M, Korde N, Shah UA, Tan C, Chung DJ, Lahoud OB, Hassoun H, Lesokhin AM, Landau HJ, Shah G, Scordo M, Giralt SA, Usmani SZ, Roshal M, Landgren O, Mailankody S. Nath K, et al. Among authors: salcedo m. Leuk Lymphoma. 2022 Dec;63(14):3488-3492. doi: 10.1080/10428194.2022.2131417. Epub 2022 Oct 25. Leuk Lymphoma. 2022. PMID: 36282633 No abstract available.
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study.
Korde N, Tavitian E, Mastey D, Lengfellner J, Hevroni G, Zarski A, Salcedo M, Mailankody S, Hassoun H, Smith EL, Hultcrantz M, Shah U, Tan C, Diamond B, Shah G, Scordo M, Lahoud O, Chung DJ, Landau H, Giralt S, Derkach A, Atkinson TM, Sabbatini P, König F, Usmani SZ, Landgren O, Lesokhin AM. Korde N, et al. Among authors: salcedo m. EClinicalMedicine. 2023 Feb 27;57:101854. doi: 10.1016/j.eclinm.2023.101854. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36895800 Free PMC article.
Multiscale Optical Imaging Fusion for Cervical Precancer Diagnosis: Integrating Widefield Colposcopy and High-Resolution Endomicroscopy.
Brenes D, Salcedo MP, Coole JB, Maker Y, Kortum A, Schwarz RA, Carns J, Vohra IS, Possati-Resende JC, Antoniazzi M, Fonseca BO, Souza KCB, Santana IVV, Barbin FF, Kreitchmann R, Ramanujam N, Schmeler KM, Richards-Kortum R. Brenes D, et al. Among authors: salcedo mp. IEEE Trans Biomed Eng. 2024 Mar 20;PP. doi: 10.1109/TBME.2024.3379898. Online ahead of print. IEEE Trans Biomed Eng. 2024. PMID: 38507389
475 results